GRASP adiponectin levels, age at death with kuru exposure, chronic kidney disease, major depressive disorder (citalopram treatment response (% change in qids-sr from baseline)), neuroblastoma (brain cancer), primary rhegmatogenous retinal detachment, schizophrenia, systolic blood pressure (sbp)